Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic experiments, and guarantees stability in exploration, maximizing reproducibility and advancing getting old and oncology investigations. each day laboratory workflows frequently reveal gaps where current compounds fall short to handle cell senescence